Ruxolitinib in clinical practice for therapy of myelofibrosis: Single USA center experience following Food and Drug Administration approval. Issue 1 (January 2014) - Geyer, Holly; Cannon, Keith; Knight, Emily; Fauble, Veena; Camoriano, John; Emanuel, Robyn; Tibes, Raoul; Mesa, Ruben